Helicobacter pylori and gastric malignancy

Helicobacter, Supplement

Volumn 10, Issue 1, 2005, Pages 34-39

  Fischbach, Wolfgang ^a   Chan, Annie On On ^b   Wong, Benjamin Chun Yu ^b  

^a KLINIKUM ASCHAFFENBURG   (Germany)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric adenocarcinoma; Gastric MALT lymphoma; Intervention study; Pathogenesis; Prevention

Indexed keywords

CANCER DIAGNOSIS; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST SUSCEPTIBILITY; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STOMACH ADENOCARCINOMA; STOMACH CANCER;

HELICOBACTER PYLORI;

EID: 25844471155     PISSN: 14784041     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00338.x     Document Type: Review

References (22)

1. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004;159:252-8.
2. Kobayashi T, Kikuchi S, Lin Y, et al. Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 2004;7:233-9.
3. Karita M, Noriyasu A, Teramukai S, Matsumoto S. Atrophic progression induced by H. pylori infection is correlated with a changing pepsinogen I value and associated with the development of gastric cancer. Dig Dis Sci 2004;49:1615-20.
4. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.
5. Yatsuya H, Toyoshima H, Tamakoshi A, et al. Japan Collaborative Cohort Study Group. Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case-control study. Br J Cancer 2004;91:929-34.
6. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host-specific colonisation during Helicobacter pylori infection. Gut 2004;53:1082-9.
7. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005;26:631-6.
8. Yang J, Hu Z, Xu Y, Shen J, Niu J, Hu X, Guo J, Wei Q, Wang X, Shen H. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 2004;215:191-8.
9. Chang YW, Jang JY, Kim NH, et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2005;114:465-71.
10. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M, Folwaczny C. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 2004;22:4746-52.
11. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-71.
12. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004;127:514-23.
13. Hirata Y, Yanai A, Shibata W, Mitsuno Y, Maeda S, Ogura K, Yoshida H, Kawabe T, Omata M. Functional variability of cagA gene in Japanese isolates of Helicobacter pylori. Gene 2004;343:165-72.
14. Basak C, Pathak SK, Bhattacharyya A, Mandal D, Pathak S, Kundu M. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem 2005;280:4279-88.
15. Xu H, Chaturvedi R, Cheng Y, et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004;64:8521-5.
16. Bussiere FI, Chaturvedi R, Cheng Y, et al. Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 2005;280:2409-12.
17. Lehours P, Dupouy S, Bergey B, et al. Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B-cell lymphoma of the MALT-type. Gut 2004;53:931-7.
18. Niv E, Bomstein Y, Bernheim J, Lishner M. Microsatellite instability in gastric MALT lymphoma. Modern Pathol 2004;17:1407-13.
19. O'Rourke JL, Dixon MF, Jack A, et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of Helicobacter beilmannii infection. J Pathol 2004;203:896-903.
20. Fischbach W, Goebeler-Kolve ME, Dragosics B, et al. Long-term outcome of patients with gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-7.
21. Inagaki H, Nakamura T, Li C, et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004;28:1560-7.
22. Goebeler ME, Savio A, Wündisch T, et al. Patients with minimal residuals of gastric MALT lymphoma after eradication of H. pylori do not need any oncological treatment: experiences from a large international series. Gastroenterology 2005;128:A-289-90.